Prognostic value of C-reactive protein in esophageal cancer: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 19, 2014, Pages 8075-8081

  Zheng, Tian Liang ^a   Cao, Ke ^b   Liang, Cui ^a   Zhang, Kai ^a   Guo, Hai Zhou ^a   Li, De Ping ^b   Zhao, Song ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b Traditional Chinese Medicine Hospital   (China)

Author keywords

C reactive protein; Esophageal cancer; Meta analysis; Prognosis

Indexed keywords

C REACTIVE PROTEIN; TUMOR MARKER;

CASE CONTROL STUDY; DISEASE COURSE; ESOPHAGUS TUMOR; HUMAN; META ANALYSIS; METABOLISM; PATHOLOGY; PROGNOSIS;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908367879     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.19.8075     Document Type: Article

References (34)

1. Chen XL, Liao YQ, Liu JR (2014). Genotype CC of rs1800947 in the C-reactive protein gene may increase susceptibility to colorectal cancer: a meta-analysis. Asian Pac J Cancer Prev, 15, 2663-7.
2. Dai J, Tang K, Xiao W, et al (2014). Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 15, 3369-75.
3. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
4. Feng JF, Zhao HG, Liu JS, et al (2013). Significance of preoperative C-reactive protein as a parameter in patients with small cell carcinoma of the esophagus. Onco Targets Ther, 6, 1147-51.
5. Fujiwara H, Suchi K, Okamura S, et al (2011). Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer. J Surg Oncol, 103, 62-8.
6. Gabay C, Kushner I (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 340, 448-54.
7. Gockel I, Dirksen K, Messow CM, et al (2006). Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol, 12, 3746-50.
8. Guillem P, Triboulet JP (2005). Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus, 18, 146-50.
9. Guo YZ, Pan L, Du CJ, et al (2013). Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pac J Cancer Prev, 14, 243-8.
10. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
11. Holmes RS, Vaughan TL (2007). Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol, 17, 2-9.
12. Hu Q, Gou Y, Sun C, et al (2014). The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis. Urol Oncol, 32, 1-8.
13. Iimura Y, Saito K, Fujii Y, et al (2009). Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. J Urol, 181, 1004-12.
14. Ikeda M, Natsugoe S, Ueno S, et al (2003). Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg, 238, 197-202.
15. Janeway CA, Jr., Medzhitov R (2002). Innate immune recognition. Annu Rev Immunol, 20, 197-216.
16. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
17. Lyronis ID, Baritaki S, Bizakis I, et al (2005). Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers, 20, 5-10.
18. Mayne ST, Navarro SA (2002). Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr, 132, 3467-70.
19. Meng YQ, Cao X, Wen ZS, et al (2014). Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma. Dis Esophagus, 27, 670-7.
20. Miyata H, Yamasaki M, Kurokawa Y, et al (2011). Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer. Exp Ther Med, 2, 879-85.
21. Motoyama S, Mori K, Kamei T, et al (2013). Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma. Ann Surg Oncol, 20, 1978-84.
22. Nakatsu T, Motoyama S, Maruyama K, et al (2012). Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes. Surg Today, 42, 652-8.
23. Nozoe T, Korenaga D, Futatsugi M, et al (2003). Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus-significance as a tumor marker. Cancer Lett, 192, 89-95.
24. Nozoe T, Saeki H, Sugimachi K (2001). Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg, 182, 197-201.
25. Shimada H, Nabeya Y, Okazumi S, et al (2003). Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol, 83, 248-52.
26. Song ZB, Lin BC, Li B, et al (2013). Preoperative elevation of serum C-reactive protein as an indicator of poor prognosis for early-stage esophageal squamous cell carcinoma. Kaohsiung J Med Sci, 29, 662-6.
27. Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25, 603-5.
28. Vakkila J, Lotze MT (2004). Inflammation and necrosis promote tumour growth. Nat Rev Immunol, 4, 641-8.
29. Vallbohmer D, Lenz HJ (2006). Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus, 19, 425-32.
30. Wang CY, Hsieh MJ, Chiu YC, et al (2009). Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy. Radiother Oncol, 92, 270-5.
31. Yu Q, Yu XF, Zhang SD, et al (2013). Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 5735-40.
32. Zeh HJ, 3rd, Lotze MT (2005). Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother, 28, 1-9.
33. Zheng Z, Zhou L, Gao S, et al (2013). Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis. Int J Med Sci, 10, 653-64.
34. Zhou B, Liu J, Wang ZM, et al (2012). C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis. PLoS One, 7, 43075.